Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets.
🔬(@nature.com): https://go.nature.com/43NHQs5
Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets.
🔬(@nature.com): https://go.nature.com/43NHQs5
- Dr. Amanda Bruegl
Learn more ➡️ bit.ly/4ozrjAl
- Dr. Amanda Bruegl
Learn more ➡️ bit.ly/4ozrjAl
We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.
Every photo represents hope, solidarity, and the shared commitment that drives our team.
Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨
Every photo represents hope, solidarity, and the shared commitment that drives our team.
Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨
- Dr. Amanda Bruegl, gynecologic oncologist at
@ohsuknight.bsky.social
- Dr. Amanda Bruegl, gynecologic oncologist at
@ohsuknight.bsky.social
- Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv
- Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv
The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ
The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ
Tissue engineering is helping close that gap.
Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew
Tissue engineering is helping close that gap.
Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew
#OHSUResearch: https://bit.ly/480D3pv
#OHSUResearch: https://bit.ly/480D3pv
The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic.
Learn more: https://bit.ly/47yeyyJ
The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic.
Learn more: https://bit.ly/47yeyyJ
Here are 🔟 facts to know about lung cancer.
Here are 🔟 facts to know about lung cancer.
- Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew
- Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew
The Maxson Lab brought the Halloween flair and festive fun to the office this year!
📸 Dr. Julia Maxson
The Maxson Lab brought the Halloween flair and festive fun to the office this year!
📸 Dr. Julia Maxson
#OHSUResearch (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
#OHSUResearch (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo
We have exceptional surgeons, specialists who tailor care to your needs, nurses who guide you through treatment, advanced options for breast reconstruction, and access to clinical trials.” - Dr. Alexandra Zimmer
We have exceptional surgeons, specialists who tailor care to your needs, nurses who guide you through treatment, advanced options for breast reconstruction, and access to clinical trials.” - Dr. Alexandra Zimmer
Early detection is crucial in the fight against cancer.
OHSU is offering breast and lung cancer screenings as part of the Pink and Pearl Campaign on Oct. 17 and Nov. 7.
Pre-registration required: https://bit.ly/4edIthO
Early detection is crucial in the fight against cancer.
OHSU is offering breast and lung cancer screenings as part of the Pink and Pearl Campaign on Oct. 17 and Nov. 7.
Pre-registration required: https://bit.ly/4edIthO